Australia agreed to introduce vaccines to China and India

China’s Sinopharm vaccine and India’s Covaxin vaccine against Covid-19 have been officially recognized by the Therapeutic Goods Authority (TGA) in Australia, allowing many international university students from the two countries to meet vaccination requirements, and return to Australia after a long border closure. So far, the TGA has only recommended vaccines approved for use in Australia: Pfizer, Moderna, AstraZeneca (now Vaxzevria), Johnson and Johnson, as well as Covishield from India and Sinovac from China. Students who have been fully vaccinated with Sinopharm or Covaxin will be able to return to Universities of New South Wales, Victoria and Queensland, which plan to accept hundreds of students per week by the start of the 2012 academic year.” When these vaccines are in widespread use, they will now be considered fully vaccinated for entry into Australia.” “This will have a significant impact on the return of international students and the entry of skilled and unskilled workers into Australia,” he adds.